| The International/Canadian hereditary angioedema guideline S Betschel, J Badiou, K Binkley, R Borici-Mazi, J Hébert, A Kanani, ... Allergy, Asthma & Clinical Immunology 15, 1-29, 2019 | 173 | 2019 |
| Part 1 results of a dose-finding study of belantamab mafodotin in combination with pomalidomide and dexamethasone for the treatment of relapsed/refractory multiple myeloma (RRMM) S Trudel, A McCurdy, HJ Sutherland, ML Louzada, CP Venner, HS Mian, ... Blood 138, 1653, 2021 | 23 | 2021 |
| Flow cytometry and immune thrombocytopenic purpura H Goubran, C Hart, I Othman, J Seghatchian Transfusion and Apheresis Science 57 (6), 800-803, 2018 | 13 | 2018 |
| Management of myeloma manifestations and complications: the cornerstone of supportive care: recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada … R LeBlanc, DJ Bergstrom, J Côté, R Kotb, ML Louzada, HJ Sutherland Clinical Lymphoma Myeloma and Leukemia 22 (1), e41-e56, 2022 | 12 | 2022 |
| Belantamab mafodotin in combination with pomalidomide and dexamethasone demonstrates durable responses in triple class exposed/refractory multiple myeloma S Trudel, A McCurdy, M Fu, HJ Sutherland, ML Louzada, MP Chu, ... Blood 140 (Supplement 1), 7306-7307, 2022 | 10 | 2022 |
| Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial S Trudel, A McCurdy, ML Louzada, S Parkin, D White, MP Chu, R Kotb, ... Nature Medicine, 1-9, 2024 | 3 | 2024 |
| Refractory acquired thrombotic thrombocytopenic purpura in a patient with sickle cell trait successfully treated with caplacizumab V Aggarwal, Z Singer, D Ledingham, I Othman Hematology 26 (1), 590-593, 2021 | 3 | 2021 |
| Hereditary hemochromatosis and JAK2‐positive polycythemia vera A Radwan, I Othman Clinical Case Reports 9 (10), e04907, 2021 | 2 | 2021 |
| Correction to: The International/Canadian Hereditary Angioedema Guideline S Betschel, J Badiou, K Binkley, R Borici-Mazi, J Hébert, A Kanani, ... Allergy, Asthma & Clinical Immunology 16, 1-2, 2020 | 2 | 2020 |
| Prevention of Ocular Toxicity Using Protective Contact Lenses in Multiple Myeloma Patients Receiving Belantamab Mafodotin, Pomalidomide and Dexamethasone: A Sub-Study of the … ML Louzada, DE Reece, A McCurdy, R Kotb, I Othman, H Mian, T Lin, ... Blood 142, 4756, 2023 | | 2023 |
| Efficacy and Tolerance of Isatuximab, Cyclophosphamide, Bortezomib, and Dexamethasone (Isa-CBD) Induction Chemotherapy in Newly Diagnosed, Transplant Eligible Multiple Myeloma … R Kotb, D White, S Bhella, A McCurdy, I Sandhu, H Mian, J Stakiw, ... Blood 142, 4751, 2023 | | 2023 |
| PB2497: HEMATOLOGIC TOXICITIES WITH IMMUNOTHERAPY IN CANCER PATIENTS AT THE ALLAN BLAIR CANCER CENTRE: RETROSPECTIVE DATA COLLECTION STUDY A Khan, I Othman, S Sanjoy, S Kassir, O Souied HemaSphere 7 (S3), e3782382, 2023 | | 2023 |
| First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium J Côté, R Kotb, DJ Bergstrom, R LeBlanc, HS Mian, I Othman, ... Clinical Lymphoma Myeloma and Leukemia 23 (5), 340-354, 2023 | | 2023 |
| Twelve tips for using ePosters as an active learning strategy K Premkumar, I Othman, H Aiyer Medical Teacher 44 (12), 1332-1339, 2022 | | 2022 |
| Retrospective Data Collection Study: Hematologic Toxicities with Immunotherapy in Cancer Patients at the Allan Blair Cancer Centre A Khan, S Kassir, O Souied, I Othman Blood 140 (Supplement 1), 13171-13171, 2022 | | 2022 |
| Novel and Experimental Clone-Directed Therapies M Elemary, I Othman Paraproteinemia and Related Disorders, 355-376, 2022 | | 2022 |
| Pembrolizumab Added to First-Line Cyclophosphamide, Bortezomib and Dexamethasone in Newly Diagnosed Transplant Non-Eligible Myeloma Patients: A Phase 2A Open Label, Multi … R Kotb, E Gul, N Abdel-Samad, I Othman, M Pavic, DE Reece Blood 138, 4768, 2021 | | 2021 |
| P-222: Extended follow-up safety and efficacy results of Belantamab mafodotin (Belamaf) 1.92 mg/kg or 2.5 mg/kg combined with POM and DEX for the treatment of relapsed … S Trudel, A McCurdy, H Sutherland, M Louzada, C Venner, D White, ... Clinical Lymphoma Myeloma and Leukemia 21, S162, 2021 | | 2021 |
| General Overview of Problem-Based Learning N Aftab, D Huynh, I Othman, O Souied Instructional Strategies in Health Professions Education, 2020 | | 2020 |
| Interdisciplinary Team Approach to Care for Oropharyngeal Cancer: A Dental Hygiene, Nursing and Medical Student Case for Problem Based Learning S Mychael, I Othman, K Sauze, O Souied Instructional Strategies in Health Professions Education, 2020 | | 2020 |
